Cargando…
Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination
Correlation between vaccine reactogenicity and immunogenicity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Thus, we investigated to determine whether the reactogenicity after coronavirus disease 2019 vaccination is associated with antibody (Ab) titers and T cell r...
Autores principales: | Lim, So Yun, Kim, Ji Yeun, Park, Soonju, Kwon, Ji-Soo, Park, Ji Young, Cha, Hye Hee, Suh, Mi Hyun, Lee, Hyun Jung, Lim, Joon Seo, Bae, Seongman, Jung, Jiwon, Lee, Nakyung, Kim, Kideok, Shum, David, Jee, Youngmee, Kim, Sung-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733188/ https://www.ncbi.nlm.nih.gov/pubmed/35036028 http://dx.doi.org/10.4110/in.2021.21.e41 |
Ejemplares similares
-
Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 Vaccines
por: Kim, Ji Yeun, et al.
Publicado: (2021) -
Breakthrough infections and waning immune responses with ChAdOx1 nCoV‐19 or mRNA vaccine in healthcare workers
por: Lim, So Yun, et al.
Publicado: (2022) -
Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without
por: Lim, So Yun, et al.
Publicado: (2022) -
Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19
por: Kim, Dong-In, et al.
Publicado: (2022) -
Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea
por: Bae, Seongman, et al.
Publicado: (2021)